• Dirk van Osch, Jan M Dieleman, Jeroen J Bunge, Diederik van Dijk, Pieter A Doevendans, Willem J Suyker, Hendrik M Nathoe, and Dexamethasone for Cardiac Surgery Study Group.
• Department of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands. Electronic address: d.vanosch@umcutrecht.nl.
• J. Thorac. Cardiovasc. Surg. 2017 Apr 1; 153 (4): 878-885.e1.

ObjectiveThe study aim was to investigate the long-term prognosis and risk factors of postpericardiotomy syndrome (PPS).MethodsWe performed a single-center cohort study in 822 patients undergoing nonemergent valve surgery. Risk factors of PPS were evaluated using multivariable logistic regression analysis. We also compared the incidence of reoperation for tamponade at 1 year between patients with and without PPS. Main secondary outcomes were hospital stay and mortality.ResultsOf the 822 patients, 119 (14.5%) developed PPS. A higher body mass index (odds ratio (OR) per point increase, 0.94; 95% confidence interval (CI), 0.89-0.99) was associated with a lower risk of PPS, whereas preoperative treatment for pulmonary disease without corticosteroids (OR, 2.55; 95% CI, 1.25-5.20) was associated with a higher risk of PPS. The incidence of reoperation for tamponade at 1 year in PPS versus no PPS was 20.9% versus 2.5% (OR, 15.49; 95% CI, 7.14-33.58). One-year mortality in PPS versus no PPS was 4.2% versus 5.5% (OR, 0.68; 95% CI, 0.22-2.08). Median hospital stay was 13 days (interquartile range, 9-18 days) versus 11 days (interquartile range, 8-15 days) (P = .001), respectively.ConclusionsDespite longer hospital stays and more short-term reoperations for tamponade, patients with PPS had an excellent 1-year prognosis.Copyright © 2016 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.

32 keywords...

hide…